Grasshopper, Action and Billy are bashers. Billy
Post# of 11802
As for a partner, no DECN's lawsuit against J&J is a catalyst not a detraction. DECN did the suing. Prospective partners should want to get in early rather than later after a J&J settlement.
The new product GenPrecis is very very promising and should be unbelievably successful and much to the chagrin of the bashers, GenPrecis will be first to market but there will be other products from other manufacturers that follow, and during its life cycle should be much more successful than any of action's favorite CGM products ... and less expensive and more precise. But, of course, that means nothing to a penny trader.